Randomized trial · people

SS-31 raised muscle ATP capacity after one dose in older adults

Checked against the paper Randomized trialPublished by PepVault

The takeaway

One elamipretide infusion briefly raised mitochondrial energy capacity in older human muscle, but in this trial that short-lived gain did not make the muscle more resistant to fatigue.

Kind
Randomized trial
Studied in
People
Number studied
39
Published
2021
Journal
PLoS One

What they tested

The team tested whether a single dose of elamipretide could improve how well mitochondria, the energy-making parts of cells, work in the muscle of older adults.

How the study was done

A randomized, double-blind, placebo-controlled trial in 39 healthy adults aged 60 to 85 (46% women), chosen because their mitochondria worked poorly. Each got one 2-hour infusion of elamipretide or placebo (a dummy treatment), and the team measured a hand muscle, the first dorsal interosseous, right after the infusion and again on day 7.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking SS-31? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Right after the infusion, the elamipretide group showed higher ATPmax than the placebo group. ATPmax is the peak rate at which muscle mitochondria make ATP, the cell's energy molecule, during exercise. The difference had P = 0.055 for the absolute change and P = 0.045 for the percent change, and by day 7 the groups no longer differed. Mitochondrial coupling at rest (P/O, how much ATP is made per unit of oxygen used) did not change significantly, and there was no significant effect on fatigue resistance during repeated contractions.

What it doesn’t show

This was one dose in a small group, measured in a single hand muscle of healthy older adults. The boost faded within a week, did not improve fatigue resistance, and the absolute change in ATPmax fell just short of the usual significance cutoff.

The paper

Roshanravan et al. In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial. PLoS One. 2021.

The compound

More studies on SS-31

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking SS-31? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo